GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: ORIC114
Compound class:
Synthetic organic
Comment: ORIC-114 is an advanced, orally bioavailable, brain penetrant EGFR and ERBB2 (HER2) inhibitor that is designed to target these receptor tyrosine kinases with oncogenic exon 20 insertion mutations in metastatic non-small-cell lung cancer and other similarly mutated solid tumours [1].
|
|
References |
1. Junttila MR, Warne R, Repellin C, Sambucetti L, Chang J, Kim S, Kim HY, Shin DG, Park DH, Patel R et al..
1345P Preclinical activity of ORIC-114, a highly selective, brain penetrant, irreversible kinase inhibitor, against atypical mutations in EGFR. Accessed on 05/05/2025. Modified on 05/05/2025. Annals of Oncology, https://www.annalsofoncology.org/article/S0923-7534(23)03215-5/fulltext |